Invention Grant
- Patent Title: Mitrecin A polypeptide with antimicrobial activity
- Patent Title (中): Mitrecin具有抗菌活性的多肽
-
Application No.: US14828127Application Date: 2015-08-17
-
Publication No.: US09562255B2Publication Date: 2017-02-07
- Inventor: Michael Heath Farris
- Applicant: The MITRE Corporation
- Applicant Address: US VA McLean
- Assignee: The MITRE Corporation
- Current Assignee: The MITRE Corporation
- Current Assignee Address: US VA McLean
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: C12Q1/18
- IPC: C12Q1/18 ; C12Q1/04 ; C12Q1/10 ; G01N33/569 ; C07K14/36

Abstract:
The present invention provides a Mitrecin A polypeptide useful in prevention and treatment of one or more bacteria. Also provided is a method to kill or prevent growth of one or more bacteria comprising contacting the one or more bacteria with a Mitrecin A polypeptide. The target bacteria can be selected from the group consisting of a Gram-positive bacterium, a Gram-negative bacterium, or both. In one embodiment, the present invention is drawn to a polynucleotide encoding a Mitrecin A polypeptide, a vector comprising the polynucleotide, a host cell comprising the polynucleotide, or a composition comprising the Mitrecin A polypeptide, the polynucleotide, the vector, or the host cell.
Public/Granted literature
- US20160032349A1 MITRECIN A POLYPEPTIDE WITH ANTIMICROBIAL ACTIVITY Public/Granted day:2016-02-04
Information query